NexgenRx Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
23.1M
P/E Ratio
16.25
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Healthcare
Health Information Services
TSXV
Key Financial Metrics
16.5M
Revenue
614,569
Net Income
C$0.01
EPS (Diluted)
832,510
Free Cash Flow
Profitability
Gross Margin
79.6%
Operating Margin
7.3%
Net Profit Margin
3.7%
EBITDA
2.3M
Returns & Efficiency
Return on Assets (ROA)
2.0%
Return on Equity (ROE)
8.1%
Dividend Yield
308.00%
Payout Ratio
-
Financial Health
Total Assets
30.5M
Total Debt
533,870
Debt to Equity
0.07x
Current Ratio
1.10
Company Info
| Industry | Health Information Services |
| HQ | Toronto, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.nexgenrx.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
14,500
Shares Sold
0
Total Transactions
1
SEDAR+ Filings
View All Filings3
Annual Reports
16
Quarterly Reports
21
MD&A
31
News Releases
2
Material Changes
10
Governance
42
Certifications
24
Other
●
2021-03-31
●
2020-04-09
●
2017-03-31
●
2018-08-24
●
2018-06-04
Interactive Charts
Company Profile
General Information
| Company Name | NexgenRx Inc. |
| Ticker | NXG.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Health Information Services |
| Headquarters | Toronto, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.nexgenrx.com |
Financial Summary
| Market Cap | 23.1M |
| Revenue | 16.5M |
| Net Income | 614,569 |
| P/E Ratio | 16.25 |
| EPS (Diluted) | C$0.01 |
| Net Margin | 3.7% |
| ROE | 8.1% |
| Dividend Yield | 308.00% |
Business Description
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.